These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 25771790)

  • 1. Combination chemotherapy of doxorubicin, all-trans retinoic acid and low molecular weight heparin based on self-assembled multi-functional polymeric nanoparticles.
    Zhang T; Xiong H; Dahmani FZ; Sun L; Li Y; Yao L; Zhou J; Yao J
    Nanotechnology; 2015 Apr; 26(14):145101. PubMed ID: 25771790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoparticle delivery and combination therapy of gambogic acid and all-trans retinoic acid.
    Yao J; Li Y; Sun X; Dahmani FZ; Liu H; Zhou J
    Int J Nanomedicine; 2014; 9():3313-24. PubMed ID: 25045262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient simultaneous tumor targeting delivery of all-trans retinoid acid and Paclitaxel based on hyaluronic acid-based multifunctional nanocarrier.
    Yao J; Zhang L; Zhou J; Liu H; Zhang Q
    Mol Pharm; 2013 Mar; 10(3):1080-91. PubMed ID: 23320642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of a paclitaxel-loaded low molecular weight heparin-all-trans-retinoid acid conjugate ternary nanoparticulate drug delivery system.
    Hou L; Yao J; Zhou J; Zhang Q
    Biomaterials; 2012 Jul; 33(21):5431-40. PubMed ID: 22521488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low molecular weight heparin-based reduction-sensitive nanoparticles for antitumor and anti-metastasis of orthotopic breast cancer.
    Sun H; Cao D; Liu Y; Wang H; Ke X; Ci T
    Biomater Sci; 2018 Jul; 6(8):2172-2188. PubMed ID: 29942949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymer-Drug Nanoparticles Combine Doxorubicin Carrier and Heparin Bioactivity Functionalities for Primary and Metastatic Cancer Treatment.
    Mei L; Liu Y; Xia C; Zhou Y; Zhang Z; He Q
    Mol Pharm; 2017 Feb; 14(2):513-522. PubMed ID: 28026951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A low-molecular-weight heparin-coated doxorubicin-liposome for the prevention of melanoma metastasis.
    Chen Y; Peng J; Han M; Omar M; Hu D; Ke X; Lu N
    J Drug Target; 2015 May; 23(4):335-46. PubMed ID: 25541466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insight into the role of dual-ligand modification in low molecular weight heparin based nanocarrier for targeted delivery of doxorubicin.
    Du H; Liu M; Yu A; Ji J; Zhai G
    Int J Pharm; 2017 May; 523(1):427-438. PubMed ID: 28359815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor targeting efficiency of bare nanoparticles does not mean the efficacy of loaded anticancer drugs: importance of radionuclide imaging for optimization of highly selective tumor targeting polymeric nanoparticles with or without drug.
    Lee BS; Park K; Park S; Kim GC; Kim HJ; Lee S; Kil H; Oh SJ; Chi D; Kim K; Choi K; Kwon IC; Kim SY
    J Control Release; 2010 Oct; 147(2):253-60. PubMed ID: 20624433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Doxorubicin-loaded amphiphilic polypeptide-based nanoparticles as an efficient drug delivery system for cancer therapy.
    Lv S; Li M; Tang Z; Song W; Sun H; Liu H; Chen X
    Acta Biomater; 2013 Dec; 9(12):9330-42. PubMed ID: 23958784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biocompatible cationic pullulan-g-desoxycholic acid-g-PEI micelles used to co-deliver drug and gene for cancer therapy.
    Chen L; Ji F; Bao Y; Xia J; Guo L; Wang J; Li Y
    Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):418-429. PubMed ID: 27770912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of low molecular weight heparin based nanoparticles for metastatic breast cancer therapy.
    Sun H; Cao D; Wu H; Liu H; Ke X; Ci T
    Int J Biol Macromol; 2018 Jun; 112():343-355. PubMed ID: 29409771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymeric nanoparticles based on chitooligosaccharide as drug carriers for co-delivery of all-trans-retinoic acid and paclitaxel.
    Zhang J; Han J; Zhang X; Jiang J; Xu M; Zhang D; Han J
    Carbohydr Polym; 2015 Sep; 129():25-34. PubMed ID: 26050884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-assembling doxorubicin-tocopherol succinate prodrug as a new drug delivery system: synthesis, characterization, and in vitro and in vivo anticancer activity.
    Duhem N; Danhier F; Pourcelle V; Schumers JM; Bertrand O; Leduff CS; Hoeppener S; Schubert US; Gohy JF; Marchand-Brynaert J; Préat V
    Bioconjug Chem; 2014 Jan; 25(1):72-81. PubMed ID: 24328289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amphiphilic peptide dendritic copolymer-doxorubicin nanoscale conjugate self-assembled to enzyme-responsive anti-cancer agent.
    Li N; Li N; Yi Q; Luo K; Guo C; Pan D; Gu Z
    Biomaterials; 2014 Nov; 35(35):9529-45. PubMed ID: 25145854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor xenografts.
    Zhong Y; Zhang J; Cheng R; Deng C; Meng F; Xie F; Zhong Z
    J Control Release; 2015 May; 205():144-54. PubMed ID: 25596560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Doxorubicin loaded silica nanorattles actively seek tumors with improved anti-tumor effects.
    Gao F; Li L; Liu T; Hao N; Liu H; Tan L; Li H; Huang X; Peng B; Yan C; Yang L; Wu X; Chen D; Tang F
    Nanoscale; 2012 Jun; 4(11):3365-72. PubMed ID: 22538830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-delivery of erlotinib and doxorubicin by pH-sensitive charge conversion nanocarrier for synergistic therapy.
    He Y; Su Z; Xue L; Xu H; Zhang C
    J Control Release; 2016 May; 229():80-92. PubMed ID: 26945977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Redox-responsive mesoporous selenium delivery of doxorubicin targets MCF-7 cells and synergistically enhances its anti-tumor activity.
    Zhao S; Yu Q; Pan J; Zhou Y; Cao C; Ouyang JM; Liu J
    Acta Biomater; 2017 May; 54():294-306. PubMed ID: 28267598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced graphene oxide nanosheets coated with an anti-angiogenic anticancer low-molecular-weight heparin derivative for delivery of anticancer drugs.
    Shim G; Kim JY; Han J; Chung SW; Lee S; Byun Y; Oh YK
    J Control Release; 2014 Sep; 189():80-9. PubMed ID: 24973719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.